FDA advisers are meeting to consider recommending the Pfizer COVID-19 vaccine for kids aged 5 to 11. Meanwhile, Moderna says its data shows a strong immune response in young children from its shot. Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss these latest developments.
